Oliver Luxxe Assets LLC decreased its stake in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) by 19.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 74,749 shares of the company’s stock after selling 18,183 shares during the period. Oliver Luxxe Assets LLC’s holdings in Envista were worth $1,970,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Dimensional Fund Advisors LP lifted its position in Envista by 1.6% in the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock worth $248,130,000 after purchasing an additional 152,488 shares during the period. Alliancebernstein L.P. raised its stake in shares of Envista by 34.0% in the 2nd quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after buying an additional 1,547,656 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Envista by 15.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock worth $72,726,000 after buying an additional 444,725 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Envista by 341.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock valued at $72,515,000 after buying an additional 2,210,847 shares during the period. Finally, Quantinno Capital Management LP lifted its holdings in shares of Envista by 38.8% in the first quarter. Quantinno Capital Management LP now owns 2,694,970 shares of the company’s stock valued at $68,371,000 after buying an additional 753,474 shares during the period.
Analysts Set New Price Targets
A number of research analysts recently issued reports on NVST shares. BMO Capital Markets assumed coverage on Envista in a report on Wednesday, July 8th. They set a “market perform” rating and a $27.00 target price on the stock. Piper Sandler reissued a “neutral” rating and issued a $28.00 price target (up from $26.00) on shares of Envista in a report on Thursday. Citigroup initiated coverage on shares of Envista in a research report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price objective for the company. Mizuho set a $29.00 price objective on shares of Envista in a research note on Thursday. Finally, Wall Street Zen downgraded shares of Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Six research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $29.31.
Envista Stock Up 3.1%
Shares of NYSE:NVST opened at $28.22 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.43. The company has a market cap of $4.59 billion, a PE ratio of 48.65, a price-to-earnings-growth ratio of 1.49 and a beta of 0.86. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42. The firm has a 50 day simple moving average of $26.03 and a 200 day simple moving average of $26.02.
Envista (NYSE:NVST – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The firm had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. During the same period in the previous year, the company posted $0.26 EPS. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, research analysts expect that Envista Holdings Corporation will post 1.53 earnings per share for the current year.
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Recommended Stories
- Five stocks we like better than Envista
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
